TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin

Immunoglobulins
UK
Published value
Not published
Submission deadline Not published
Lots published6
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS ENGLAND: "NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin". Published status: complete. Published value: Value not published. 6 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS ENGLANDScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS ENGLAND
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS ENGLAND. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS ENGLAND
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published29 Nov 2024, 15:46 GMT
Last source update29 Nov 2024, 15:46 GMT
Recurring procurementNot published
ClassificationImmunoglobulins
Delivery area
UK
OCIDocds-h6vhtk-04c141
What is being bought
NHS England has recently awarded a framework for Human Albumin & Normal and Anti-D Immunoglobulin
What changed
From the official release history
  1. Status changed to complete
    29 Nov 2024, 15:46 GMT
  2. Official notice release published
    29 Nov 2024, 15:46 GMT
  3. Buyer information updated
    29 Nov 2024, 15:46 GMT
Lots and requirements (6)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
    Status not published
    Published valueNot published
    5% Intravenous Immunoglobulin (5% IVIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - 10% Intravenous Immunoglobulin (10% IVIg)
    Status not published
    Published valueNot published
    10% Intravenous Immunoglobulin (10% IVIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Lot 3: Subcutaneous Immunoglobulin (SCIg)
    Status not published
    Published valueNot published
    Subcutaneous Immunoglobulin (SCIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
    Status not published
    Published valueNot published
    5% Intravenous Immunoglobulin (5% IVIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
    Status not published
    Published valueNot published
    10% Intravenous Immunoglobulin (10% IVIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #6
    Lot 7: Subcutaneous Immunoglobulin (SCIg)
    Status not published
    Published valueNot published
    Subcutaneous Immunoglobulin (SCIg)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    29 Nov 2024, 15:46 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 23 Jun 2021, 00:00 BST · £400,000,000
Commercial outcome and competition
Awards
Bio Products Laboratory Ltd, CSL Behring UK Ltd, Grifols UK Ltd, LFB Biopharmaceuticals Ltd
Not published · Not published · active
Contracts
Contract
£400,000,000 · signed 23 Jun 2021, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS ENGLAND

Contracting authority GB-FTS-131655
View buyer profile

  • NHS ENGLAND
    buyer

    WELLINGTON HOUSE,133-155 WATERLOO ROAD, LONDON, UKI45, SE18UG
    darryn.boardman@nhs.net
    +44 7702410392

  • Bio Products Laboratory Ltd
    supplier

    GB-COH: 0734036
    Elstree, UK

  • CSL Behring UK Ltd
    supplier

    GB-COH: 01622483
    Haywards Heath, UK

  • Grifols UK Ltd
    supplier

    GB-COH: 01456099
    London, UK

  • LFB Biopharmaceuticals Ltd
    supplier

    GB-COH: 06058711
    London, UK

  • The High Court
    reviewBody

    London
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleExplanation provided in section VI.3. Additional information